John Wirthlin

John Wirthlin is an experienced executive with a diverse background in leadership roles within the biotechnology and technology sectors. Currently serving as Portfolio CEO at Wasatch Equity Partners and Founding Partner at Summit Bioservices, Wirthlin has a proven track record as Chief Executive Officer of Metrodora Institute, a medical institute focused on chronic complex conditions, and has held various key positions at Lumea, AlloCure, Nephrogen GmbH, Echelon Biosciences, SunGard, and Utah Technology Finance Corporation. Wirthlin's educational credentials include a Bachelor's Degree from the University of Utah and an MBA from Westminster University.